Skip to content

Clinical investigation on the safety and performance of the ABLE Daily to assist people with spinal cord injury in home and community settings

Clinical investigation on the safety and performance of the ABLE Daily to assist people with spinal cord injury in home and community settings - ABLEdailySCI

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57428
Enrollment
10
Registered
2024-12-10
Start date
2025-06-19
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

paraplegia Spinal cord injury spinal cord injury

Interventions

ABLE Daily exoskeleton use in the home and community settings.

Sponsors

ABLE Human Motion
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: At least 18 years old Chronic SCI (>6 months) Injury at levels T1 to L5 (AIS A to D) Walking Index Spinal Cord Injury (WISCII) 0 till 9 Between 150-200 cm  Weight less than 100 kilograms Capable of giving informed consent on their own Able to train (at least) 3 days/week Able to have at least 1 companion/buddy who can attend a minimum of two of the  training sessions, besides the Final assessment, and who will learn how to  assist them at home and in the community. (ideally two companions)

Exclusion criteria

Exclusion criteria: High risk of fractures due to osteoporosis, a dual energy X-ray absorptiometry  (DEXA)-scan at the hip T-score < -3.5 and for the distal femur and proximal tibia T-score < -3 Fragility fractures of the lower limbs in the last 2 years Deterioration >3 in the International Standards for Neurological Classification  of SCI (ISNCSCI) score in the last 4 weeks Spinal instability, like spondylolisthesis Disorders of the arms and hands that make walking with crutches impossible Modified Ashworth Scale (MAS) >3 in lower limbs Cardiovascular health issues which prevent the participant from training Inability to tolerate 10 minutes of standing without clinical symptoms of  orthostatic hypotension Psychological, cognitive issues, or any other condition that does not allow a  participant to follow study procedures Medically unstable due to severe comorbidities, including any condition that a  physician deems inappropriate for completing study participation Skin problems in areas that would be in contact with the device Height, width, weight, or other anatomical limitations (such as differences in  leg length) incompatible with the device Insufficient joint range of motion (ROM) for the device Known pregnancy

Design outcomes

Primary

MeasureTime frame
The primary objective of this study is to confirm the safety and performance of the ABLE Daily to perform ambulatory functions in home and community settings for people with spinal cord injury.

Secondary

MeasureTime frame
The secondary objectives are to assess the impact of the ABLE Daily use on the perceived general health of the participants, the gait performance with the ABLE Daily using data collected from the exoskeleton, and the level of user satisfaction from participants, companions, and therapists.

Countries

Netherlands

Contacts

Public ContactD Oosterling

Sint Maartenskliniek

d.oosterling@maartenskliniek.nl024 365 9911

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026